Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|March 16, 2011
Stroke and transient ischemic attack in the long-term care setting: patient characteristics, medication treatment, and length of stayJuliana L Meyers, Keith L Davis, Yanni F Yu
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 16, 2010
Estimating the effect of medication adherence on health outcomes among patients with type 2 diabetes--an application of marginal structural modelsAndrew P Yu, Yanni F Yu, Michael B Nichol
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 11, 2005
Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the california medicaid programYanni F Yu, Michael B Nichol, Andrew P Yu, et al.
Clinical Therapeutics|May 24, 2008
Delay in filling the initial prescription for a statin: a potential early indicator of medication nonpersistenceAndrew Peng Yu, Yanni F Yu, Michael B Nichol, et al.
The American Journal of Managed Care|August 25, 2016
Association of Part D coverage gap with COPD medication adherenceYanni F Yu, Larry R Hearld, Haiyan Qu, et al.
BMC Pulmonary Medicine|December 31, 2015
Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosisWilliam M Reichmann, Yanni F Yu, Dendy Macaulay, et al.
Respiratory Medicine|November 27, 2015
Association of early suspected acute exacerbations of idiopathic pulmonary fibrosis with subsequent clinical outcomes and healthcare resource utilizationYanni F Yu, Dendy S Macaulay, William M Reichmann, et al.
Journal of Medical Economics|November 28, 2014
Healthcare resource utilization among patients diagnosed with idiopathic pulmonary fibrosis in the United StatesNing Wu, Yanni F Yu, Chien-Chia Chuang, et al.
Managed Care Interface|October 5, 2006
Comparison of costs associated with the use of etanercept, infliximab, and adalimumab for the treatment of rheumatoid arthritisMichael F Bullano, Brian J McNeeley, Yanni F Yu, et al.
Journal of Managed Care & Specialty Pharmacy|March 30, 2016
Patterns and Economic Burden of Hospitalizations and Exacerbations Among Patients Diagnosed with Idiopathic Pulmonary FibrosisYanni F Yu, Ning Wu, Chien-Chia Chuang, et al.
Pageof 1